2021 Revenues ($USD) : $4,164,034,848 2021 Revenues (foreign currencies) : RMB26,861,356,000 2021 R&D spend : $570,046,971 2021 Number of Employees : 25,579 Fiscal Year End : 12/31/2021 Leader : CEO Li Yi
[Image courtesy of Sino Biopharm]
Sino Biopharm is a research-driven pharmaceutical conglomerate based in mainland China. The company markets various biopharmaceutical and chemical medicines for treating tumors, liver diseases, orthopedic diseases, infections, respiratory system diseases and more. The core business in the group is the ChiaTai Tianqing Pharmaceutical Group. Sino Biopharm also developes modernized Chinese medicine as well as biopharma products. The company was founded in 2000. —BB
Tell Us What You Think!
You must be logged in to post a comment.